New biorenewables technology moves closer to marketplace
Licensing agreement between startup Hyrax and WARF to accelerate commercial development
Category: Investment, Renewable Energy
News about Hyrax Energy
MADISON, Wis. - October 22, 2012 (Investorideas.com renewable energy newswire) A licensing agreement for a novel renewable chemical and biofuel production method between Hyrax Energy and the Wisconsin Alumni Research Foundation promises to accelerate commercial development of the technology and lead to high-quality U.S. jobs.
Developed in the laboratory of Ron Raines, a University of Wisconsin-Madison biochemistry professor and a Hyrax founder, the technology provides a new way to transform cellulosic biomass into renewable fuels and high-value chemicals. The chemical process, developed with support from the Great Lakes Bioenergy Research Center on the UW-Madison campus, uses ionic liquids to break down cellulosic or non-food plant biomass without using enzymes or costly pretreatment steps.
The company's process creates fermentable sugars, which can be converted into a variety of important chemicals, including fuels and plastics.
"Gaining this licensing agreement for the patent-pending technology allows the company to move forward with its business plan for implementing the technology on a commercial scale," Raines said. "The combination of the license for this technology and Hyrax's own intellectual property outlines a clear path toward delivering high-value products to a diverse customer base."
Jennifer Gottwald, a licensing manager for WARF who specializes in clean technologies, said the agreement highlights the ways in which university research drives commercial innovation and creates benefits for society.
"Using waste materials such as corn stover and forestry byproducts, society may now have a way to produce high-value fuels and chemicals that improve the efficiency of the agricultural industry while reducing our nation's reliance on imported fossil fuels," she said.
The process developed in the lab avoids the need for costly pretreatment efforts typically used to overcome key problems with biomass including its water-insolubility and resistance to molecular deconstruction. The technology avoids these problems by employing ionic liquids to dissolve raw biomass from the beginning.
"Doing the entire conversion process in ionic liquids eliminates enzymes, pretreatment steps and harsh energy inputs and leads to a dramatic reduction in process complexity and capital intensity," Raines said. Coupled with its scientific significance, the licensing of the new technology marks a major step toward commercializing this approach to biofuel production on an industrial scale.
"Hyrax has done considerable market research into the cost of ionic liquids and developed a process model that has been validated by third parties. The economic advantages of this approach far outweigh the costs," Raines said. "We have been fortunate to have the support of the Great Lakes Bioenergy Research Center and WARF Accelerator Program to fund development of the technology and provide the intellectual property protection necessary to support the process of commercialization."
Hyrax is the first company to emerge from research at the Great Lakes Bioenergy Research Center, which was established in 2007. The center generates advances in basic science that can lead to new commercial opportunities based on biofuels. Hyrax previously won the prestigious 2012 Clean Energy Challenge sponsored by the Clean Energy Trust.
About Hyrax Energy
Founded in 2011 to pursue bioenergy opportunities, the company's ionic liquids platform combines hydrolysis chemistry developed at UW-Madison with a separations technology developed by the company that recycles the ionic liquid very efficiently. The process generates high yields starting from forestry residues, corn stover and dedicated energy crops and produces a clean, concentrated fermentable sugar product that can be converted into innumerable chemicals or drop-in biofuels. The startup is currently raising capital and plans to hire a small number of employees in the coming year.
About the Great Lakes Bioenergy Research Center
Established in 2007 as one of three bioenergy research centers funded by the U.S. Department of Energy's Office of Science, the Great Lakes Bioenergy Research Center performs the basic research that generates technology to convert cellulosic biomass to ethanol and other advanced biofuels. With more than 400 scientists, students and staff representing a wide array of disciplines from microbiology to economics and engineering, the center is working to meet the nation's need for a comprehensive suite of clean energy technologies, including next generation and drop-in fuels that can be used by today's engines. To date, there are more than four dozen patent applications pending for discoveries made by scientists affiliated with the center.
Since its founding in 1925 to manage a UW-Madison discovery that eventually eliminated the childhood disease rickets, WARF has been working with industry to transform university research into products that benefit society. As a private, nonprofit organization, WARF accomplishes its mission of supporting scientific research by patenting and licensing inventions arising from university discoveries. Since making its first grant of $1,200 in 1928, WARF has contributed more than $1 billion to UW-Madison through annual "margin of excellence'' grants and other funding. For more information, visit www.warf.org.
This news is published on the Investorideas.com Newswire and its syndicated partner network
Get free news alerts:
Sign up here
Published at the Investorideas.com Newswire - Big ideas for Global Investors
Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news as well as creates original content as a news source. Original content created by investor ideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and global syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions and advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.